Wakamoto Pharmaceutical Co (TSE:4512) EV-to-Revenue : 0.67 (As of Jun. 10, 2024)

Wakamoto Pharmaceutical Co EV-to-Revenue Chart

Wakamoto Pharmaceutical Co Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					0.62	0.48	1.37	0.83	0.56

Wakamoto Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.49	0.56	0.45	0.47	0.49

Competitive Comparison of Wakamoto Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wakamoto Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Wakamoto Pharmaceutical Co's EV-to-Revenue falls into.

Wakamoto Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Wakamoto Pharmaceutical Co's EV-to-Revenue for today is calculated as:

Wakamoto Pharmaceutical Co's current Enterprise Value is 円5,320 Mil.
Wakamoto Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7,979 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wakamoto Pharmaceutical Co  (TSE:4512) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Wakamoto Pharmaceutical Co's PS Ratiofor today is calculated as:

Wakamoto Pharmaceutical Co's share price for today is 円253.00.
Wakamoto Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円229.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wakamoto Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Wakamoto Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Wakamoto Pharmaceutical Co (TSE:4512) Business Description